A limited supply of cannabis in the U.S. means those resources have to be divvied up carefully. For Cronos Group, that means keeping its medical and recreational marijuana operations in completely different verticals, CEO Michael Gorenstein told Cheddar. That ensures patients’ needs are prioritized over those of recreational users. “If you think about building a town, and you have a limited amount of building supplies, we want to make sure that we’re building a hospital before we’re building the bar,” he said. Canada-based Cronos Group started trading on the NASDAQ on Tuesday, making it the first marijuana company to list on a major U.S. market. “It’s a big milestone not just for us but for the entire industry,” said Gorenstein. “[It] just continues to show the acceptance that the cannabis industry is getting.” And the industry does seem to be growing at break-neck speed. Arcview, a leading researcher of the cannabis market, stated in a [recent report](https://arcviewgroup.com/product/5th-edition/) that the industry brought in $9.7 billion in sales in 2017, and that number could grow to over $25 billion by 2021. For the full interview, [click here](https://cheddar.com/videos/inside-the-first-cannabis-company-to-list-on-nasdaq).

Share:
More In Business
Black Innovation Alliance Working to Empower Black Entrepreneurs
The Black Innovation Alliance is working to empower Black entrepreneurs and recently received a $3 million commitment from UBS to help with resources. Ifeoma Ike, director of policy and movement strategy with the Black Innovation Alliance, joined Cheddar News to explain further the organization's mission.
Stocks Close on Final Day of February
Shana Sissel, president & CEO of Banrion Capital Management, joined Cheddar News to discuss another down day on the last session of the month in trading as inflation, a restricted monetary policy, and layoffs continue to affect markets.
Load More